TD Cowen upgrades Flagstar Bank stock rating on earnings recovery

TD Cowen upgraded Flagstar Bank (FLG) to Buy and raised its price target to $18.00 from $15.00, implying ~23% upside from $14.59, citing a more durable earnings recovery. The note highlights structural balance-sheet tailwinds: $12B of <3.8% multifamily/commercial real estate loans resetting or maturing through 2027 and reinvestment into SOFR+225–240 bps C&I loans, with loan growth expected to inflect in 2Q26 (>$1.8B, >10% QoQ). Net interest margin is forecast to rise from 2.15% (1Q26) to ~2.50% (4Q26) and ~2.85% (4Q27), alongside 15% NII growth for 2026 and 27% for 2027.

Analysis

FLG screens as a delayed-earnings turnaround rather than a near-term growth story, which matters because the market usually pays up only after the balance-sheet math becomes visible in quarterly numbers. The real catalyst is not the upgrade itself but the spread between legacy low-yield CRE assets and redeployed C&I loans, plus a funding-cost reset that can mechanically lift NIM without heroic credit assumptions. That combination can drive multiple expansion if management proves the mix shift is sustainable, but it is still a 2H26 story, not a next-quarter story.

Second-order, FLG’s improving funding profile could force competitors in the Northeast regional bank set to defend share with less favorable deposit pricing, especially if rate cuts remain shallow and wholesale funding stays expensive. The loser set is any bank still carrying a heavy book of lower-yielding CRE with limited repricing runway; those names will look cheaper on P/B until the market realizes their earnings power is more rate-sensitive and less self-help driven. CRE borrowers facing 2026-2027 refis are also the hidden pressure point: if credit losses re-accelerate, the NIM story can be overwhelmed by reserve builds.

The contrarian risk is that investors may be extrapolating the 2026-2027 NII ramp while ignoring that the company already missed revenue expectations in the latest quarter. If loan growth stalls, deposit costs re-accelerate, or CRE performance worsens, the upgrade can fade quickly because the current valuation still implies a lot of trust in execution. The cleanest falsifier is any sign that 2Q26 loan growth does not inflect and that deposit costs stay stuck above peers; that would push the story back into a value trap narrative.

Key Decisions for Investors

• Buy FLG on weakness, not strength: accumulate on pullbacks toward the low-$14s with a 3-6 month target near $18; invalidation below ~$13.25 if management commentary on loan growth or deposit repricing softens.
• Use options for the back-half 2026 catalyst: buy FLG Jan-2027 $15/$20 call spreads to express the NIM expansion story with limited downside; payoff improves materially if the stock rerates into the expected 2026 inflection.
• Relative-value pair: long FLG / short KRE for a 6-9 month horizon to isolate idiosyncratic balance-sheet cleanup versus the broader regional bank beta; exit if FLG fails to show accelerating C&I growth by mid-2026.
• Watchlist, not trade yet: if quarterly interest-bearing deposit costs do not move from the low-3% area toward the peer range by 2H26, cut exposure because the funding-cost thesis is not gaining traction.
• If using the event window, take partial profits into analyst-driven spikes; the strongest upside is in the next 2-4 quarters, but the stock can give back gains if the market starts discounting credit risk instead of earnings power.